tiprankstipranks
KALA BIO (KALA)
NASDAQ:KALA
US Market
KALA
KALA BIO
RESEARCH TOOLSreports

KALA BIO (KALA) Financial Statements

Compare
1,583 Followers

KALA BIO Financial Overview

KALA BIO's market cap is currently $182.27M. The company's EPS TTM is $; its P/E ratio is -0.36; KALA BIO is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 3.89M$ 11.24M$ 6.36M
Gross Profit$ -259.00K$ -303.00K$ 1.33M$ 7.14M$ 3.19M
Operating Income$ -40.98M$ -39.15M$ -81.36M$ -109.43M$ -96.23M
EBITDA$ -40.98M$ -36.08M$ -36.70M$ -131.96M$ -92.90M
Net Income$ -38.51M$ -42.20M$ -44.82M$ -142.60M$ -104.33M
Balance Sheet
Cash & Short-Term Investments$ 51.18M$ 50.90M$ 70.50M$ 92.14M$ 153.54M
Total Assets$ 55.48M$ 55.95M$ 86.82M$ 139.43M$ 221.61M
Total Debt$ 32.25M$ 36.32M$ 42.95M$ 80.19M$ 100.92M
Net Debt$ -18.93M$ -14.57M$ -27.55M$ -11.95M$ 23.65M
Total Liabilities$ 43.15M$ 48.45M$ 67.85M$ 122.62M$ 121.61M
Stockholders' Equity$ 12.33M$ 7.50M$ 18.97M$ 16.80M$ 100.00M
Cash Flow
Free Cash Flow$ -29.59M$ -28.54M$ -79.22M$ -109.12M$ -92.64M
Operating Cash Flow$ -29.38M$ -27.93M$ -78.91M$ -108.23M$ -90.69M
Investing Cash Flow$ -208.00K$ -429.00K$ 62.72M$ 70.80M$ -78.21M
Financing Cash Flow$ 29.88M$ 8.51M$ -7.94M$ 42.55M$ 160.63M
Currency in USD

KALA BIO Earnings and Revenue History

Income Statement >

KALA BIO Debt to Assets

Balance Sheet >

KALA BIO Cash Flow

Cash Flow >

KALA BIO Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >